nivolumab,ipilimumab,cabozantinib
bms
['rcc,(-irccs),(-srcc),(-urcc)', 'cosmic313', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'cabo ', 'nivo']
another man, another legend. presents updates from #cosmic313 in #kidneycancer of note, pts w poor risk disease had similar duration of treatment and median cabo dose. adds to drama of triplets. poor risk rcc still needs effective therapies. #gu23 
I treat & research GU cancers @UTSW Dallas. Columbia/Harvard Med/Duke alum; Mom & wife Tweets=my opinions ASCO: https://t.co/Whk29PATXe